Kennedy defends Trump claims on drug discounts

Summary

Kennedy told senators Trump “has a different way of calculating” prescription drug discounts, defending claims that exceed 100%.

Why this matters

The exchange highlights scrutiny of how the Trump administration describes prescription drug savings. It also underscores the importance of clear, accurate pricing claims for consumers comparing drug costs.

Health Secretary Robert F. Kennedy Jr. defended President Donald Trump’s calculation of prescription drug discounts during a Senate Finance Committee hearing on Wednesday, saying the president “has a different way of calculating.”

“If you have a $600 drug, and you reduce it to $10, that’s a 600% reduction,” Kennedy said.

A drop from $600 to $10 is a discount of more than 98%. A discount cannot exceed 100% without reducing the price to zero or below.

Sen. Elizabeth Warren, D-Mass., raised the issue while questioning Kennedy about Protonix, a prescription drug listed on the federally run TrumpRx website, compared with the price of a generic version at Costco. Warren said some Americans using TrumpRx were still paying more for drugs.

She also referred to Trump’s repeated claims that TrumpRx offered discounts of 400% to 1,500%. “Which I think means companies should be paying you to take their drugs,” Warren said.

Kennedy initially did not address Warren’s question about Protonix pricing and instead defended Trump’s math.

Trump has made similar claims since promoting TrumpRx, which began with deals announced last year with pharmaceutical companies to lower some drug prices.

He later said the discount depended “on how you want to calculate it.”

On March 25, Trump again said, “We have lowered the price of drugs by 50, 60, 70 and 80 and 90%. And there’s another way of figuring, you could also say, depending on the way you phrased the statement, 400, 500, 600, 700%. Nobody’s ever seen anything like it.”

  • Conspiracy theories spread after dinner shooting

    By midday Sunday, the term “staged” had appeared in more than 300,000 posts on X, according to social media analytics firm TweetBinder.

    Full story +

  • Reports say U.S. limited North Korea intel to Seoul

    Seoul, Washington did not confirm reports that the U.S. curtailed some intelligence sharing after remarks about a North Korean nuclear site.

    Full story +

  • ,

    California Pipeline Dispute Tests State, Federal Power

    The Texas company’s pipeline system had been idle since a 2015 rupture caused a major oil spill that fouled beaches from Santa Barbara to Los Angeles and harmed marine wildlife and fisheries.

    Full story +

  • China blocks Meta-Manus deal after review

    China’s top economic planner said it blocked Meta’s acquisition of Singapore-based AI startup Manus and ordered the deal unwound.

    Full story +

  • Rubio cites Iran divisions as obstacle in talks

    Rubio said divisions within Iran’s leadership limited what its negotiators could offer in talks with the U.S.

    Full story +

  • Australia proposes tax on Meta, Google, TikTok

    It is Australia’s second legislative effort to require platforms to pay for Australian news content.

    Full story +

  • Supreme Court weighs Bayer bid to curb Roundup suits

    Bayer has said Roundup litigation has cost it more than $10 billion and weighed on its share price.

    Full story +

  • Attack in northeast Nigeria kills at least 29

    The Islamic State West Africa Province claimed responsibility.

    Full story +

  • Oil rises to three-week high

    Brent crude rose above $111, bringing its weekly gain to nearly 6%, while West Texas Intermediate traded above $98.

    Full story +

  • Oil rises to three-week high

    Brent crude rose above $111, bringing its weekly gain to nearly 6%, while West Texas Intermediate traded above $98.

    Full story +